Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

May 12, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • Covid-19 vaccine

Tag: Covid-19 vaccine

  • BiotechToday
  • World

Refrigeration-free COVID-19 vaccines are cultured on plants and bacteria

bioxone September 19, 2021September 19, 2021 1

Sneha Singhal, Jaypee Institute of information technology, Noida COVID-19 vaccine candidates developed by researchers at UC San Diego can withstand the heat. What are their key ingredients? Plant or bacterial viruses. Vaccine technology: We are still in the early phases of developing the new refrigerator-free COVID-19 vaccine. Vaccine candidates stimulated the mice to produce high […]

Read More
  • BiotechToday
  • World

Understanding the potential of the Coronavirus alpha variant

BioTech Today July 3, 2021July 3, 2021 3

Neha khan, Jamia Millia Islamia What is the alpha variant? The B.1.1.7 variant is known as the Alpha variant which was first found in India and had taken thousands of lives. This coronavirus variant is more infectious than other variants because it foils the innate immune system for a while till it replicates and finds […]

Read More
  • BiotechToday
  • World

A drug to reduce Covid infection by 99%

BioTech Today June 29, 2021June 28, 2021 5

Vaishnavi Kardale, Bioinformatics Centre, Savitribai Phule Pune University All over the world research is currently focused on the development of a drug that might help cure COVID19. At the moment we do not have any treatment for COVID19. Vaccines are the only way the chain of transmission can be broken. Throughout the pandemic, various drugs […]

Read More
  • BiotechToday
  • World

Molnupiravir: The real game-changer for COVID-19?

bioxone March 20, 2021March 20, 2021 3

Shagufta Hasan, Amity University Kolkata  The world has had hard knocks with COVID-19 vaccines but no drug seems to give full coverage against the virus, but now, it may hope for good news. A new drug, Molnupiravir, has been developed by Merck & Co. Inc in association with Ridgeback Biotherapeutics, a biotechnology company, focused on […]

Read More
  • BiotechToday
  • India

Tata to launch Moderna COVID-19 vaccine in India

bioxone January 28, 2021January 28, 2021 1

Srilagna Sarkar, Amity University Kolkata Tata Medical and Diagnostics are in talks to team up with India’s Council of Scientific and Industrial Research in order to carry out Moderna’s vaccine candidate in India. Tata Group’s healthcare venture is said to have started the initial discussion with Moderna Inc on partnership in launching its COVID-19 vaccine […]

Read More
  • BiotechToday
  • India

INDIA’S CALL FOR PFIZER AGAINST COVID 19

bioxone December 8, 2020December 8, 2020 1

SHRESTHA DUTTA, AMITY UNIVERSITY KOLKATA The authorization for Pfizer’s vaccine candidate came in just 10 months since it initiated developing it, which is the fastest in the history of vaccines. Pfizer has become the main organization to seek emergency use endorsement of its immunization applicant in India after getting clearance in the UK and Bahrain. […]

Read More
  • BiotechToday
  • World

Pfizer— coming to rescue from next week.

bioxone December 3, 2020December 3, 2020

Shrestha Dutta, Amity University Kolkata England affirmed Pfizer COVID-19 antibody on Wednesday, hoping in front of the United States and Europe to turn into the West’s first nation to officially embrace a hit it said should reach the most susceptible individuals early next week. PM Boris Johnson promoted the medication authority’s endorsement as a worldwide […]

Read More
  • BiotechToday
  • World

mRNA-1273 shows promising results after Phase 3 trial

bioxone November 19, 2020November 19, 2020 1

Prama Ghosh, Amity University Kolkata An interim review shared by an independent data and safety monitoring board (DSMB) about mRNA-1273 – a COVID-19 vaccine overseeing its Phase 3 trial suggests that the vaccine is safe and effective at preventing symptomatic COVID-19 in adults after its interim analysis with the trial oversight group on Nov. 15, 2020.  […]

Read More
  • BiotechToday
  • India

Moderna: Covid-19 Vaccine- Sooner than we think?

bioxone November 1, 2020November 1, 2020 1

Avipsha Datta, Department of Biophysics and Molecular Biology, University of Calcutta Covid-19 Vaccine- the one thing we are very much hoping for right now! Well, here is some news update that might give us a little more hope. The Drugmaker Company Moderna has announced that it is preparing to launch its potential Coronavirus vaccine mRNA-1273.Meanwhile, […]

Read More
  • Biotechnopedia
  • DNA-Tales

mRNA vaccine: Efforts to dethrone coronavirus at the transcriptional level

bioxone October 27, 2020October 27, 2020 1

Ayushman Kumar Banerjee With over 43 million COVID-19 cases having surfaced and more than 1.1 million deaths, researchers are relentlessly working round the clock to develop vaccines against the virus, SARS-CoV-2, which causes the COVID-19. This has led to a race for a vaccine against the novel coronavirus, and in this race, Moderna has devised […]

Read More

Posts navigation

1 2

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy